Finally, the gene expression patterns of cancer cell lines from the Genomics of Drug Sensitivity in Cancer database were combined in order to comprehensively investigate the potential therapeutic benefit of the EIF4A1, EIF4G4, NCBP1, and WDR4 genes. The gene discussed is EIF4A1; the disease is cancer.